Expression of β-nerve growth factor and homeobox A10 in experimental cryptorchidism treated with exogenous nerve growth factor

Xian,Hua; Xian,Yun; Liu,Lili; Wang,Yongjun; He,Jianghong; Huang,Jianfei

doi:10.3892/mmr.2014.3005

Expression of β-nerve growth factor and homeobox A10 in experimental cryptorchidism treated with exogenous nerve growth factor

Authors:
- Hua Xian
- Yun Xian
- Lili Liu
- Yongjun Wang
- Jianghong He
- Jianfei Huang
View Affiliations

Affiliations: Department of Pediatric Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China, Department of Public Health College, Nantong University, Nantong, Jiangsu 226001, P.R. China, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, P.R. China, Department of Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China
Published online on: November 26, 2014 https://doi.org/10.3892/mmr.2014.3005
Pages: 2875-2881

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

With the exception of standard inguinal orchidopexy, treatment of cryptorchidism with human chorionic gonadotropin has been performed for several years; however, its side effects have limited its application. The β‑nerve growth factor (NGF) and homeobox A10 (HoxA10) genes are closely associated with the development of the testes. To the best of our knowledge, whether exogenous NGF alters the endogenous levels of NGF and HoxA10 in cryptorchidism in rats remains to be elucidated. The aim of the present study was to evaluate the gene and protein expression of NGF and HoxA10 in experimental cryptorchidism following treatment with exogenous NGF. A unilateral mechanical cryptorchidism model in Sprague-Dawley rats was established and different concentrations of exogenous NGF were administered to observe the effects of NGF on cryptorchidism. Changes in the gene and protein expression levels of NGF and HoxA10 in the cryptorchid tissues of each group were identified using one step reverse transcription-quantitative polymerase chain reaction, in situ hybridization with digoxigenin‑labeled‑β‑NGF RNA probes, immunofluorescence and immunohistochemistry, respectively. The expression levels of NGF and HoxA10 were markedly higher in the group treated with a high dose of exogenous NGF compared with the group treated with a low dose of exogenous NGF and the group treated with human chorionic gonadotropin. These results confirmed the potential therapeutic effect of exogenous NGF in human cryptorchidism.

View Figures

View References

1	Ashley RA, Barthold JS and Kolon TF: Cryptorchidism: pathogenesis, diagnosis, treatment and prognosis. Urol Clin North Am. 37:183–193. 2010. View Article : Google Scholar : PubMed/NCBI
2	Wohlfahrt-Veje C, Boisen KA, Boas M, et al: Acquired cryptorchidism is frequent in infancy and childhood. Int J Androl. 32:423–428. 2009. View Article : Google Scholar : PubMed/NCBI
3	Sijstermans K, Hack WW, Meijer RW and van der Voort-Doedens LM: The frequency of undescended testis from birth to adulthood: a review. Int J Androl. 31:1–11. 2008.
4	Hadziselimovic NO, de Geyter C, Demougin P, Oakeley EJ and Hadziselimovic F: Decreased expression of FGFR1, SOS1, RAF1 genes in cryptorchidism. Urol Int. 84:353–361. 2010. View Article : Google Scholar : PubMed/NCBI
5	Zivkovic D, Bica DG and Hadziselimovic F: Effects of hormonal treatment on the contralateral descended testis in unilateral cryptorchidism. J Pediatr Urol. 2:468–472. 2006. View Article : Google Scholar
6	Ferlin A, Zuccarello D, Zuccarello B, Chirico MR, Zanon GF and Foresta C: Genetic alterations associated with cryptorchidism. JAMA. 300:2271–2276. 2008. View Article : Google Scholar : PubMed/NCBI
7	Thorsson AV, Christiansen P and Ritzén M: Efficacy and safety of hormonal treatment of cryptorchidism: current state of the art. Acta Paediatr. 96:628–630. 2007. View Article : Google Scholar : PubMed/NCBI
8	Kaleva M and Toppari J: Cryptorchidism: an indicator of testicular dysgenesis? Cell Tissue Res. 322:167–172. 2005. View Article : Google Scholar : PubMed/NCBI
9	Zhang L, Zheng XM, Hubert J, Zheng H, Yang ZW and Li SW: Prenatal exposure to diaethylstilbestrol in the rat inhibits transabdominal testicular descent with involvement of the INSL3/LGR8 system and HOXA10. Chin Med J (Engl). 122:967–971. 2009.
10	Levi-Montalcini R and Hamburger V: Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool. 116:321–361. 1951. View Article : Google Scholar : PubMed/NCBI
11	Levi-Montalcini R: The nerve growth factor 35 years later. Science. 237:1154–1162. 1987. View Article : Google Scholar : PubMed/NCBI
12	Xian H, Xian Y, Jiang CY, et al: Decreased expression of beta-nerve growth factor correlated with histological changes in a cryptorchidism rat model. Chin Med J (Engl). 125:713–716. 2012.
13	Levi-Montalcini R, Dal Toso R, della Valle F, Skaper SD and Leon A: Update of the NGF saga. J Neurol Sci. 130:119–127. 1995. View Article : Google Scholar : PubMed/NCBI
14	Seidl K and Holstein AF: Evidence for the presence of nerve growth factor (NGF) and NGF receptors in human testis. Cell Tissue Res. 261:549–554. 1990. View Article : Google Scholar : PubMed/NCBI
15	Ayer-LeLievre C, Olson L, Ebendal T, Hallböök F and Persson H: Nerve growth factor mRNA and protein in the testis and epididymis of mouse and rat. Proc Natl Acad Sci USA. 85:2628–2632. 1988. View Article : Google Scholar : PubMed/NCBI
16	Jin W, Tanaka A, Watanabe G, Matsuda H and Taya K: Effect of NGF on the motility and acrosome reaction of golden hamster spermatozoa in vitro. J Reprod Dev. 56:437–443. 2010. View Article : Google Scholar : PubMed/NCBI
17	Persson H, Ayer-Le Lievre C, Söder O, et al: Expression of beta-nerve growth factor receptor mRNA in Sertoli cells downregulated by testosterone. Science. 247:704–707. 1990. View Article : Google Scholar : PubMed/NCBI
18	Williams BJ, Eriksdotter-Jonhagen M and Granholm AC: Nerve growth factor in treatment and pathogenesis of Alzheimer’s disease. Prog Neurobiol. 80:114–128. 2006. View Article : Google Scholar : PubMed/NCBI
19	Albeck D, Mesches MH, Juthberg S, et al: Exogenous NGF restores endogenous NGF distribution in the brain of the cognitively impaired aged rat. Brain Res. 967:306–310. 2003. View Article : Google Scholar : PubMed/NCBI
20	Hou W, Hu J, Li Y, et al: Altered expression of NDRG2 in the testes of experimental rat model of cryptorchidism. Urology. 75:985–991. 2010. View Article : Google Scholar : PubMed/NCBI
21	Tena-Sempere M, Kero J, Rannikko A and Huhtaniemi I: Experimental cryptorchidism induces a change in the pattern of expression of LH receptor mRNA in rat testis after selective Leydig cell destruction by ethylene dimethane sulfonate. J Endocrinol. 161:131–141. 1999. View Article : Google Scholar : PubMed/NCBI
22	Perrard MH, Chassaing E, Montillet G, Sabido O and Durand P: Cytostatic factor proteins are present in male meiotic cells and beta-nerve growth factor increases mos levels in rat late spermatocytes. PLoS One. 4:e72372009. View Article : Google Scholar : PubMed/NCBI
23	Moretti E, Di Cairano G, Capitani S, Scapigliati G, Baccetti B and Collodel G: Cryptorchidism and semen quality: a TEM and molecular study. J Androl. 28:194–199. 2007. View Article : Google Scholar
24	Absalan F, Movahedin M and Mowla SJ: Germ cell apoptosis induced by experimental cryptorchidism is mediated by molecular pathways in mouse testis. Andrologia. 42:5–12. 2010. View Article : Google Scholar : PubMed/NCBI